Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections

NCT00174811 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

639

Enrollment

INDUSTRY

Sponsor class

Stopped Pediatric development program terminated by sponsor

Conditions

Otitis Media

Interventions

DRUG: telithromycin (HMR3647)

Sponsor

Sanofi